Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
1902 1
1905 2
1909 1
1910 3
1911 1
1912 1
1914 4
1915 1
1918 1
1919 1
1920 3
1921 1
1922 2
1923 4
1924 3
1925 1
1926 3
1927 1
1929 1
1930 3
1931 2
1932 4
1933 1
1935 1
1943 1
1944 1
1948 1
1949 1
1950 2
1951 5
1952 1
1953 2
1955 2
1956 1
1958 1
1959 1
1960 2
1962 2
1963 1
1968 1
1970 1
2000 1
2006 1
2008 1
2009 1
2010 5
2011 6
2012 9
2013 6
2014 9
2015 11
2016 11
2017 9
2018 5
2019 7
2020 4
2021 2
2023 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 26722064

152 results
Results by year
Filters applied: . Clear all
Page 1
Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Coens C, van der Graaf WT, Blay JY, Chawla SP, Judson I, Sanfilippo R, Manson SC, Hodge RA, Marreaud S, Prins JB, Lugowska I, Litière S, Bottomley A. Coens C, et al. Cancer. 2015 Sep 1;121(17):2933-41. doi: 10.1002/cncr.29426. Epub 2015 May 29. Cancer. 2015. PMID: 26033286 Free article. Clinical Trial.
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials.
Duffaud F, Sleijfer S, Litière S, Ray-Coquard I, Le Cesne A, Papai Z, Judson I, Schöffski P, Chawla SP, Dewji R, Marreaud S, Verweij J, van der Graaf WT. Duffaud F, et al. Eur J Cancer. 2015 Nov;51(17):2615-23. doi: 10.1016/j.ejca.2015.08.002. Epub 2015 Aug 25. Eur J Cancer. 2015. PMID: 26321011
152 results